canrenoic acid has been researched along with Ventricular Dysfunction, Left in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belle, L; Beygui, F; Cayla, G; Collet, JP; Cornillet, L; Delarche, N; Ecollan, P; Furber, A; Galinier, M; Goldstein, P; Lebon, A; Legallois, D; Machecourt, J; Montalescot, G; Motreff, P; Roubille, F; Roule, V; Rousseau, H; Silvain, J; Van Belle, E; Vicaut, E; Zannad, F | 1 |
1 trial(s) available for canrenoic acid and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial.
Topics: Age Factors; Aged; Canrenoic Acid; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Sex Factors; Single-Blind Method; Spironolactone; Statistics, Nonparametric; Survival Analysis; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2016 |